Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 284(51): 35564-71, 2009 Dec 18.
Article in English | MEDLINE | ID: mdl-19840942

ABSTRACT

Paraoxonases (PONs) are a family of lactonases with promiscuous enzyme activity that has been implicated in multiple diseases. PON2 is intracellularly located, is the most ubiquitously expressed PON, and has the highest lactonase activity of the PON family members. Whereas some single-nucleotide polymorphisms (SNPs) in PON1 have resulted in altered enzymatic activity in serum, to date the functional consequences of SNPs on PON2 function remain unknown. We hypothesized that a common PON2 SNP would result in impaired lactonase activity. Substitution of cysteine for serine at codon 311 in recombinant PON2 resulted in normal protein production and localization but altered glycosylation and decreased lactonase activity. Moreover, we screened 200 human lung samples for the PON2 Cys(311) variant and found that in vivo this mutation impaired lactonase activity. These data suggest that impaired lactonase activity may play a role in innate immunity, atherosclerosis, and other diseases associated with the PON2 311 SNP.


Subject(s)
Aryldialkylphosphatase/metabolism , Atherosclerosis/enzymology , Immunity, Innate , Polymorphism, Single Nucleotide , Amino Acid Substitution , Animals , Aryldialkylphosphatase/genetics , Atherosclerosis/genetics , CHO Cells , Cricetinae , Cricetulus , Glycosylation , Humans , Lung/enzymology
2.
J Immunol ; 170(5): 2613-20, 2003 Mar 01.
Article in English | MEDLINE | ID: mdl-12594289

ABSTRACT

TGF-beta is a potent regulatory cytokine that suppresses expression of inducible NO synthase and IFN-gamma, and suppresses Th1 and Th2 cell development. We examined whether functionally active TGF-beta is present in the local environment surrounding the invading protozoan Leishmania chagasi. Our prior data showed that TGF-beta levels are significantly increased in L. chagasi-infected mice. In the current study, we found TGF-beta was also abundant in bone marrows of humans with acute visceral leishmaniasis but not in those of uninfected controls. Furthermore, L. chagasi infection caused an increase in biologically active TGF-beta in human macrophage cultures without changing the total TGF-beta. Therefore, we investigated the means through which leishmania could augment activated but not total TGF-beta. Incubation of latent TGF-beta with Leishmania sp. promastigotes caused active TGF-beta to be released from the latent complex. In contrast, the nonpathogenic protozoan Crithidia fasciculata could not activate TGF-beta. TGF-beta activation by leishmania was prevented by inhibitors of cysteine proteases and by the specific cathepsin B inhibitor CA074. Physiologic concentrations of TGF-beta inhibited killing of intracellular L. chagasi in macrophages, although the phagocytosis-induced respiratory burst remained intact. In contrast, supraphysiologic concentrations of TGF-beta had no effect on parasite survival. We hypothesize that the combined effect of abundant TGF-beta stores at extracellular sites during infection, and the ability of the parasite to activate TGF-beta in its local environment, leads to high levels of active TGF-beta in the vicinity of the infected macrophage. Locally activated TGF-beta could, in turn, enhance parasite survival through its effects on innate and adaptive immune responses.


Subject(s)
Leishmania infantum/growth & development , Leishmania infantum/immunology , Macrophages/immunology , Macrophages/parasitology , Transforming Growth Factor beta/metabolism , Animals , Cells, Cultured , Crithidia fasciculata/immunology , Host-Parasite Interactions/immunology , Humans , Leishmania infantum/pathogenicity , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/parasitology , Macrophages/enzymology , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , NADPH Oxidases/metabolism , Oxidative Stress/immunology , Transforming Growth Factor beta/physiology
3.
Eur J Immunol ; 32(12): 3556-65, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12516540

ABSTRACT

Cure of leishmaniasis requires a type 1 immune response characterized by IFN-gamma production. Leishmania major infection leads to a type 2 response suppressing cure of susceptible BALB/c mice, and L. major causes an exacerbated type 2 response in mouse strains with a gene knockout (KO) such that they lack IL-12p40 (IL-12KO mice). In contrast, type 1 responses are inhibited by TGF-beta without Th2 cell expansion in BALB/c mice infected with L. chagasi. We questioned whether the type 2 or the TGF-beta response would dominate during L. chagasi infection of IL-12KO mice. C57BL/6 mice developed self-resolving L. chagasi infection with abundant IFN-gamma. In contrast, L. chagasi disease was exacerbated and IFN-gamma was low in IL-12KO mice. Total TGF-beta was significantly higher in IL-12KO than control C57BL/6 mice, but IL-4 and IL-10 levels were similar. TGF-beta was further augmented in IL-12/IFN-gamma double-KO mice. Thus, in contrast to L. major, the TGF-beta response was exacerbated whereas type 2 cells were not expanded during L. chagasi infection of IL-12KO mice. We conclude that L. chagasi has an inherent propensity to elicit a prominent TGF-beta response that either suppresses, or is suppressed by, a type 1 response. We propose this be termed a "type 3" immune response, which can antagonize a type 1 response.


Subject(s)
Interleukin-12/deficiency , Leishmania infantum/immunology , Leishmaniasis, Visceral/immunology , Transforming Growth Factor beta/biosynthesis , Animals , Dendritic Cells/immunology , Immunization, Passive , Interferon-gamma/deficiency , Interferon-gamma/genetics , Interleukin-10/biosynthesis , Interleukin-12/genetics , Interleukin-4/biosynthesis , Mice , Mice, Inbred C57BL , Mice, Knockout , Th1 Cells/immunology , Th2 Cells/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...